Antoine Bridier-Nahmias

Associate Professor

Université Paris Cité

France

Research Interests

Explore related searches

Professors in France Professors in Microbiology Microbiology professors in France

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Antoine Bridier-Nahmias is an Associate Professor at Université Paris Cité, France. His research focuses on microbiome dynamics, antimicrobial resistance, and viral evolution, with recent publications examining the genetic diversity of Escherichia coli and the phylodynamics of SARS-CoV-2. He has contributed significantly to understanding the transmission and resistance patterns of infectious agents in various clinical contexts.

Articles (12)

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Collaborators (2)

Benoit Visseaux

Université Paris Cité

FRANCE

View details

Jerome LeGoff

FRANCE

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Antoine Bridier-Nahmias

Research Interests

Explore related searches

Contact this professor

About

Articles (12)

Genomic evidence of Escherichia coli gut population diversity translocation in leukemia patients

Faecal carriage of extended-spectrum β-lactamase-producing Escherichia coli in a remote region of Niger

Temporal dynamics of RSV shedding and genetic diversity in adults during the COVID-19 pandemic in a French hospital, early 2021

Phylodynamics of SARS-CoV-2 in France, Europe, and the world in 2020

Azithromycin Resistance in Shiga Toxin-Producing Escherichia coli in France between 2004 and 2020 and Detection of mef(C)-mph(G) Genes

Nosocomial transmission clusters and lineage diversity characterized by SARS-CoV-2 genomes from two large hospitals in Paris, France, in 2020

The 16S rRNA lung microbiome in mechanically ventilated patients: a methodological study

Modeling the bacterial dynamics in the gut microbiota following an antibiotic-induced perturbation

Emergence of E484K Mutation Following Bamlanivimab Monotherapy among High-Risk Patients Infected with the Alpha Variant of SARS-CoV-2

Long term SARS-CoV-2 infectiousness among three immunocompromised patients: from prolonged viral shedding to SARS-CoV-2 superinfection.

Escherichia coli Genomic Diversity within Extraintestinal Acute Infections Argues for Adaptive Evolution at Play

Escherichia coli O80 hybrid pathotype strains producing Shiga toxin and ESBL: molecular characterization and potential therapeutic options

Collaborators (2)

Benoit Visseaux

Jerome LeGoff

Make your next move.